{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:22:07Z","timestamp":1789590127624,"version":"build-2803163510"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12645-9","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T13:56:48Z","timestamp":1753365408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Haloperidol drug repurposing unveils ferroptosis involvement in breast cancer cells"],"prefix":"10.1038","volume":"15","author":[{"given":"Valeria","family":"Consoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Sorrenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Saccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Federico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico Andrea","family":"Cristaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Pittal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Intagliata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Vanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"12645_CR1","doi-asserted-by":"publisher","unstructured":"Consoli, V. et al. Heme Oxygenase modulation drives ferroptosis in TNBC cells. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms23105709 (2022).","DOI":"10.3390\/ijms23105709"},{"key":"12645_CR2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41572-019-0111-2","volume":"5","author":"N Harbeck","year":"2019","unstructured":"Harbeck, N. et al. Breast cancer. Nat. Rev. Dis. Primers. 5, 66. https:\/\/doi.org\/10.1038\/s41572-019-0111-2 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"12645_CR3","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00439-018-1944-6","volume":"137","author":"SA Narod","year":"2018","unstructured":"Narod, S. A. Personalised medicine and population health: breast and ovarian cancer. Hum. Genet. 137, 769\u2013778. https:\/\/doi.org\/10.1007\/s00439-018-1944-6 (2018).","journal-title":"Hum. Genet."},{"key":"12645_CR4","doi-asserted-by":"publisher","first-page":"10091","DOI":"10.1038\/s41598-023-35125-4","volume":"13","author":"GP Col\u00f3","year":"2023","unstructured":"Col\u00f3, G. P. et al. Proteomic analysis of the effect of Hemin in breast cancer. Sci. Rep. 13, 10091. https:\/\/doi.org\/10.1038\/s41598-023-35125-4 (2023).","journal-title":"Sci. Rep."},{"key":"12645_CR5","doi-asserted-by":"publisher","unstructured":"Greish, K. et al. Curcumin\u207bcopper complex nanoparticles for the management of triple-negative breast cancer. Nanomaterials (Basel). 8. https:\/\/doi.org\/10.3390\/nano8110884 (2018).","DOI":"10.3390\/nano8110884"},{"key":"12645_CR6","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1021\/acsmedchemlett.4c00099","volume":"15","author":"V Consoli","year":"2024","unstructured":"Consoli, V. et al. Synthesis and in vitro evaluation of CAPE derivatives as ferroptosis inducers in triple negative breast cancer. ACS Med. Chem. Lett. 15, 706\u2013713. https:\/\/doi.org\/10.1021\/acsmedchemlett.4c00099 (2024).","journal-title":"ACS Med. Chem. Lett."},{"key":"12645_CR7","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/nm.3595","volume":"20","author":"SM Strittmatter","year":"2014","unstructured":"Strittmatter, S. M. Overcoming drug development bottlenecks with repurposing: old drugs learn new tricks. Nat. Med. 20, 590\u2013591. https:\/\/doi.org\/10.1038\/nm.3595 (2014).","journal-title":"Nat. Med."},{"key":"12645_CR8","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1134\/S1068162023020139","volume":"49","author":"VS Kulkarni","year":"2023","unstructured":"Kulkarni, V. S., Alagarsamy, V., Solomon, V. R., Jose, P. A. & Murugesan, S. Drug repurposing: an effective tool in modern drug discovery. Russ J. Bioorg. Chem. 49, 157\u2013166. https:\/\/doi.org\/10.1134\/S1068162023020139 (2023).","journal-title":"Russ J. Bioorg. Chem."},{"key":"12645_CR9","doi-asserted-by":"publisher","first-page":"100713","DOI":"10.1016\/j.drup.2020.100713","volume":"52","author":"J Dini\u0107","year":"2020","unstructured":"Dini\u0107, J. et al. Repurposing old drugs to fight multidrug resistant cancers. Drug Resist. Updat. 52, 100713. https:\/\/doi.org\/10.1016\/j.drup.2020.100713 (2020).","journal-title":"Drug Resist. Updat"},{"key":"12645_CR10","doi-asserted-by":"publisher","first-page":"32907","DOI":"10.1021\/acsomega.0c03495","volume":"5","author":"GM Asong","year":"2020","unstructured":"Asong, G. M. et al. A mechanistic investigation on the anticancer properties of SYA013, a homopiperazine analogue of haloperidol with activity against triple negative breast Cancer cells. ACS Omega. 5, 32907\u201332918. https:\/\/doi.org\/10.1021\/acsomega.0c03495 (2020).","journal-title":"ACS Omega"},{"key":"12645_CR11","doi-asserted-by":"publisher","first-page":"5053","DOI":"10.1021\/acs.molpharmaceut.4c00468","volume":"21","author":"A Ansari","year":"2024","unstructured":"Ansari, A. et al. Lipid-Conjugated reduced haloperidol in association with glucose-based nanospheres: A strategy for glioma treatment. Mol. Pharm. 21, 5053\u20135070. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.4c00468 (2024).","journal-title":"Mol. Pharm."},{"key":"12645_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","volume":"9","author":"Q Zhou","year":"2024","unstructured":"Zhou, Q. et al. Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies. Signal. Transduct. Target. Ther. 9, 55. https:\/\/doi.org\/10.1038\/s41392-024-01769-5 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"12645_CR13","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.tpj.6500373","volume":"6","author":"Z Wei","year":"2006","unstructured":"Wei, Z., Mousseau, D. D., Dai, Y., Cao, X. & Li, X. M. Haloperidol induces apoptosis via the sigma2 receptor system and Bcl-XS. Pharmacogenomics J. 6, 279\u2013288. https:\/\/doi.org\/10.1038\/sj.tpj.6500373 (2006).","journal-title":"Pharmacogenomics J."},{"key":"12645_CR14","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/jm101530j","volume":"54","author":"K Pal","year":"2011","unstructured":"Pal, K. et al. Structure-activity study to develop cationic lipid-conjugated haloperidol derivatives as a new class of anticancer therapeutics. J. Med. Chem. 54, 2378\u20132390. https:\/\/doi.org\/10.1021\/jm101530j (2011).","journal-title":"J. Med. Chem."},{"key":"12645_CR15","doi-asserted-by":"publisher","first-page":"7926","DOI":"10.1021\/acs.jmedchem.0c02265","volume":"64","author":"AN Fallica","year":"2021","unstructured":"Fallica, A. N. et al. Recent advances in the development of Sigma receptor ligands as cytotoxic agents: A medicinal chemistry perspective. J. Med. Chem. 64, 7926\u20137962. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c02265 (2021).","journal-title":"J. Med. Chem."},{"key":"12645_CR16","doi-asserted-by":"publisher","first-page":"117032","DOI":"10.1016\/j.bmc.2022.117032","volume":"73","author":"AN Fallica","year":"2022","unstructured":"Fallica, A. N. et al. Structure-activity relationships of mixed \u03c3. Bioorg. Med. Chem. 73, 117032. https:\/\/doi.org\/10.1016\/j.bmc.2022.117032 (2022).","journal-title":"Bioorg. Med. Chem."},{"key":"12645_CR17","doi-asserted-by":"publisher","unstructured":"Papadopoulos, F. et al. Haloperidol induced cell cycle arrest and apoptosis in glioblastoma cells. Biomedicines 8 https:\/\/doi.org\/10.3390\/biomedicines8120595 (2020).","DOI":"10.3390\/biomedicines8120595"},{"key":"12645_CR18","doi-asserted-by":"publisher","first-page":"e468","DOI":"10.1016\/j.wneu.2019.04.180","volume":"128","author":"Z Liu","year":"2019","unstructured":"Liu, Z. et al. Synergistic suppression of glioblastoma cell growth by combined application of Temozolomide and dopamine D2 receptor antagonists. World Neurosurg. 128, e468\u2013e477. https:\/\/doi.org\/10.1016\/j.wneu.2019.04.180 (2019).","journal-title":"World Neurosurg."},{"key":"12645_CR19","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s12640-022-00606-3","volume":"40","author":"K Doello","year":"2022","unstructured":"Doello, K. et al. Antitumor effect of traditional drugs for neurological disorders: preliminary studies in neural tumor cell lines. Neurotox. Res. 40, 1645\u20131652. https:\/\/doi.org\/10.1007\/s12640-022-00606-3 (2022).","journal-title":"Neurotox. Res."},{"key":"12645_CR20","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1016\/j.ejca.2009.07.011","volume":"45","author":"V M\u00e9galizzi","year":"2009","unstructured":"M\u00e9galizzi, V. et al. Screening of anti-glioma effects induced by sigma-1 receptor ligands: potential new use for old anti-psychiatric medicines. Eur. J. Cancer. 45, 2893\u20132905. https:\/\/doi.org\/10.1016\/j.ejca.2009.07.011 (2009).","journal-title":"Eur. J. Cancer"},{"key":"12645_CR21","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/acschemneuro.2c00398","volume":"13","author":"Y Hirata","year":"2022","unstructured":"Hirata, Y. et al. Haloperidol prevents oxytosis\/ferroptosis by targeting lysosomal ferrous ions in a manner independent of dopamine D2 and Sigma-1 receptors. ACS Chem. Neurosci. 13, 2719\u20132727. https:\/\/doi.org\/10.1021\/acschemneuro.2c00398 (2022).","journal-title":"ACS Chem. Neurosci."},{"key":"12645_CR22","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.bbrc.2017.07.136","volume":"491","author":"T Bai","year":"2017","unstructured":"Bai, T. et al. Haloperidol, a Sigma receptor 1 antagonist, promotes ferroptosis in hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 491, 919\u2013925. https:\/\/doi.org\/10.1016\/j.bbrc.2017.07.136 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12645_CR23","doi-asserted-by":"publisher","unstructured":"Consoli, V., Sorrenti, V., Grosso, S. & Vanella, L. Heme oxygenase-1 signaling and redox homeostasis in physiopathological conditions. Biomolecules 11. (2021). https:\/\/doi.org\/10.3390\/biom11040589","DOI":"10.3390\/biom11040589"},{"key":"12645_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05119-5","author":"V Consoli","year":"2024","unstructured":"Consoli, V., Sorrenti, V., Gulisano, M., Spampinato, M. & Vanella, L. Navigating Heme pathways: the breach of Heme Oxygenase and Hemin in breast cancer. Mol. Cell. Biochem. Doi. https:\/\/doi.org\/10.1007\/s11010-024-05119-5 (2024).","journal-title":"Mol. Cell. Biochem. Doi"},{"key":"12645_CR25","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2017.12.025","volume":"416","author":"LC Chang","year":"2018","unstructured":"Chang, L. C. et al. Heme oxygenase-1 mediates BAY 11-7085 induced ferroptosis. Cancer Lett. 416, 124\u2013137. https:\/\/doi.org\/10.1016\/j.canlet.2017.12.025 (2018).","journal-title":"Cancer Lett."},{"key":"12645_CR26","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1159\/000065686","volume":"24","author":"S Gonzales","year":"2002","unstructured":"Gonzales, S., Erario, M. A. & Tomaro, M. L. Heme oxygenase-1 induction and dependent increase in ferritin. A protective antioxidant stratagem in hemin-treated rat brain. Dev. Neurosci. 24, 161\u2013168. https:\/\/doi.org\/10.1159\/000065686 (2002).","journal-title":"Dev. Neurosci."},{"key":"12645_CR27","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1042\/BJ20120936","volume":"449","author":"L Lanceta","year":"2013","unstructured":"Lanceta, L., Li, C., Choi, A. M. & Eaton, J. W. Haem oxygenase-1 overexpression alters intracellular iron distribution. Biochem. J. 449, 189\u2013194. https:\/\/doi.org\/10.1042\/BJ20120936 (2013).","journal-title":"Biochem. J."},{"key":"12645_CR28","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1073\/pnas.1821022116","volume":"116","author":"X Fang","year":"2019","unstructured":"Fang, X. et al. Ferroptosis as a target for protection against cardiomyopathy. Proc. Natl. Acad. Sci. U S A. 116, 2672\u20132680. https:\/\/doi.org\/10.1073\/pnas.1821022116 (2019).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"12645_CR29","doi-asserted-by":"publisher","first-page":"F702","DOI":"10.1152\/ajprenal.00044.2017","volume":"314","author":"O Adedoyin","year":"2018","unstructured":"Adedoyin, O. et al. Heme oxygenase-1 mitigates ferroptosis in renal proximal tubule cells. Am. J. Physiol. Ren. Physiol. 314, F702\u2013F714. https:\/\/doi.org\/10.1152\/ajprenal.00044.2017 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"12645_CR30","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun, X. et al. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63, 173\u2013184. https:\/\/doi.org\/10.1002\/hep.28251 (2016).","journal-title":"Hepatology"},{"key":"12645_CR31","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41420-021-00473-5","volume":"7","author":"ZH Wu","year":"2021","unstructured":"Wu, Z. H., Tang, Y., Yu, H. & Li, H. D. The role of ferroptosis in breast cancer patients: a comprehensive analysis. Cell. Death Discov. 7, 93. https:\/\/doi.org\/10.1038\/s41420-021-00473-5 (2021).","journal-title":"Cell. Death Discov"},{"key":"12645_CR32","doi-asserted-by":"publisher","unstructured":"Miller, R. P., Tadagavadi, R. K., Ramesh, G. & Reeves, W. B. Mechanisms of cisplatin nephrotoxicity. Toxins (Basel)  2 2490\u2009\u2013\u2009518. (2010). https:\/\/doi.org\/10.3390\/toxins2112490","DOI":"10.3390\/toxins2112490"},{"key":"12645_CR33","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1620\/tjem.219.177","volume":"219","author":"LP Rybak","year":"2009","unstructured":"Rybak, L. P., Mukherjea, D., Jajoo, S. & Ramkumar, V. Cisplatin ototoxicity and protection: clinical and experimental studies. Tohoku J. Exp. Med. 219, 177\u2013186. https:\/\/doi.org\/10.1620\/tjem.219.177 (2009).","journal-title":"Tohoku J. Exp. Med."},{"key":"12645_CR34","doi-asserted-by":"publisher","first-page":"629150","DOI":"10.3389\/fcell.2021.629150","volume":"9","author":"H Wang","year":"2021","unstructured":"Wang, H. et al. A promising future of ferroptosis in tumor therapy. Front. Cell. Dev. Biol. 9, 629150. https:\/\/doi.org\/10.3389\/fcell.2021.629150 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"12645_CR35","doi-asserted-by":"publisher","first-page":"571127","DOI":"10.3389\/fonc.2020.571127","volume":"10","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. Ferroptosis in Cancer treatment: another way to Rome. Front. Oncol. 10, 571127. https:\/\/doi.org\/10.3389\/fonc.2020.571127 (2020).","journal-title":"Front. Oncol."},{"key":"12645_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1006\/bbrc.1996.0208","volume":"219","author":"PJ Brent","year":"1996","unstructured":"Brent, P. J., Pang, G., Little, G., Dosen, P. J. & Van Helden, D. F. The Sigma receptor ligand, reduced haloperidol, induces apoptosis and increases intracellular-free calcium levels [Ca2+]i in colon and mammary adenocarcinoma cells. Biochem. Biophys. Res. Commun. 219, 219\u2013226. https:\/\/doi.org\/10.1006\/bbrc.1996.0208 (1996).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"12645_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s12032-024-02323-7","volume":"41","author":"S Harris","year":"2024","unstructured":"Harris, S., Nagarajan, P. & Kim, K. The cytotoxic effects of prazosin, chlorpromazine, and haloperidol on hepatocellular carcinoma and immortalized non-tumor liver cells. Med. Oncol. 41, 87. https:\/\/doi.org\/10.1007\/s12032-024-02323-7 (2024).","journal-title":"Med. Oncol."},{"key":"12645_CR38","doi-asserted-by":"publisher","first-page":"9960","DOI":"10.1021\/acs.jmedchem.6b01039","volume":"59","author":"M Olivieri","year":"2016","unstructured":"Olivieri, M. et al. Antiangiogenic effect of (\u00b1)-Haloperidol metabolite II valproate ester [(\u00b1)-MRJF22] in human microvascular retinal endothelial cells. J. Med. Chem. 59, 9960\u20139966. https:\/\/doi.org\/10.1021\/acs.jmedchem.6b01039 (2016).","journal-title":"J. Med. Chem."},{"key":"12645_CR39","doi-asserted-by":"publisher","unstructured":"Sorrenti, V. et al. Tin mesoporphyrin selectively reduces non-small-cell lung cancer cell line A549 proliferation by interfering with Heme Oxygenase and glutathione systems. Biomolecules 11. (2021). https:\/\/doi.org\/10.3390\/biom11060917","DOI":"10.3390\/biom11060917"},{"key":"12645_CR40","doi-asserted-by":"publisher","first-page":"e202300047","DOI":"10.1002\/cmdc.202300047","volume":"18","author":"L Salerno","year":"2023","unstructured":"Salerno, L. et al. Discovery of SI 1\/20 and SI 1\/22 as mutual prodrugs of 5-Fluorouracil and Imidazole-based Heme Oxygenase 1 inhibitor with improved cytotoxicity in DU145 prostate Cancer cells. ChemMedChem 18, e202300047. https:\/\/doi.org\/10.1002\/cmdc.202300047 (2023).","journal-title":"ChemMedChem"},{"key":"12645_CR41","doi-asserted-by":"publisher","first-page":"105428","DOI":"10.1016\/j.bioorg.2021.105428","volume":"117","author":"G Floresta","year":"2021","unstructured":"Floresta, G. et al. Growing the molecular architecture of imidazole-like ligands in HO-1 complexes. Bioorg. Chem. 117, 105428. https:\/\/doi.org\/10.1016\/j.bioorg.2021.105428 (2021).","journal-title":"Bioorg. Chem."},{"key":"12645_CR42","doi-asserted-by":"publisher","unstructured":"Sturiale, V. et al. Cell cycle reactivation, at the start of neurodegeneration, induced by forskolin and aniline in differentiated neuroblastoma cells. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241814373 (2023).","DOI":"10.3390\/ijms241814373"},{"key":"12645_CR43","doi-asserted-by":"publisher","first-page":"9176357","DOI":"10.1155\/2016\/9176357","volume":"2016","author":"Z Cesarz","year":"2016","unstructured":"Cesarz, Z. & Tamama, K. Spheroid culture of mesenchymal stem cells. Stem Cells Int. 2016, 9176357. https:\/\/doi.org\/10.1155\/2016\/9176357 (2016).","journal-title":"Stem Cells Int."},{"key":"12645_CR44","doi-asserted-by":"publisher","first-page":"13724","DOI":"10.1073\/pnas.1008117107","volume":"107","author":"TJ Bartosh","year":"2010","unstructured":"Bartosh, T. J. et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc. Natl. Acad. Sci. U. S. A. 107, 13724\u201313729. https:\/\/doi.org\/10.1073\/pnas.1008117107 (2010).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"12645_CR45","doi-asserted-by":"publisher","unstructured":"Cristaldi, D. A. et al. A reliable flow-based method for the accurate measure of mass density, size and weight of live 3D tumor spheroids. Micromachines (Basel) 11. (2020). https:\/\/doi.org\/10.3390\/mi11050465","DOI":"10.3390\/mi11050465"},{"key":"12645_CR46","doi-asserted-by":"publisher","first-page":"101328","DOI":"10.1016\/j.redox.2019.101328","volume":"28","author":"G Miotto","year":"2020","unstructured":"Miotto, G. et al. Insight into the mechanism of ferroptosis Inhibition by ferrostatin-1. Redox Biol. 28, 101328. https:\/\/doi.org\/10.1016\/j.redox.2019.101328 (2020).","journal-title":"Redox Biol."},{"key":"12645_CR47","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042 (2012).","journal-title":"Cell"},{"key":"12645_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.peptides.2017.03.006","volume":"91","author":"JL Riis","year":"2017","unstructured":"Riis, J. L. et al. Adiponectin: Serum-saliva associations and relations with oral and systemic markers of inflammation. Peptides 91, 58\u201364. https:\/\/doi.org\/10.1016\/j.peptides.2017.03.006 (2017).","journal-title":"Peptides"},{"key":"12645_CR49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao, M., Monian, P., Quadri, N., Ramasamy, R. & Jiang, X. Glutaminolysis and transferrin regulate ferroptosis. Mol. Cell. 59, 298\u2013308. https:\/\/doi.org\/10.1016\/j.molcel.2015.06.011 (2015).","journal-title":"Mol. Cell."},{"key":"12645_CR50","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41419-023-06045-y","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu, Y., Lu, S., Wu, L. L., Yang, L. & Wang, J. The diversified role of mitochondria in ferroptosis in cancer. Cell. Death Dis. 14, 519. https:\/\/doi.org\/10.1038\/s41419-023-06045-y (2023).","journal-title":"Cell. Death Dis."},{"key":"12645_CR51","doi-asserted-by":"publisher","first-page":"24393","DOI":"10.18632\/oncotarget.5162","volume":"6","author":"MY Kwon","year":"2015","unstructured":"Kwon, M. Y., Park, E., Lee, S. J. & Chung, S. W. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget 6, 24393\u201324403. https:\/\/doi.org\/10.18632\/oncotarget.5162 (2015).","journal-title":"Oncotarget"},{"key":"12645_CR52","doi-asserted-by":"publisher","first-page":"115164","DOI":"10.18632\/oncotarget.23046","volume":"8","author":"SH Hong","year":"2017","unstructured":"Hong, S. H. et al. Molecular crosstalk between ferroptosis and apoptosis: emerging role of ER stress-induced p53-independent PUMA expression. Oncotarget 8, 115164\u2013115178. https:\/\/doi.org\/10.18632\/oncotarget.23046 (2017).","journal-title":"Oncotarget"},{"key":"12645_CR53","doi-asserted-by":"publisher","first-page":"102170","DOI":"10.1016\/j.redox.2021.102170","volume":"47","author":"J Wu","year":"2021","unstructured":"Wu, J. et al. The non-canonical effects of Heme oxygenase-1, a classical fighter against oxidative stress. Redox Biol. 47, 102170. https:\/\/doi.org\/10.1016\/j.redox.2021.102170 (2021).","journal-title":"Redox Biol."},{"key":"12645_CR54","doi-asserted-by":"publisher","first-page":"20621","DOI":"10.1074\/jbc.M607954200","volume":"282","author":"Q Lin","year":"2007","unstructured":"Lin, Q. et al. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. J. Biol. Chem. 282, 20621\u201320633. https:\/\/doi.org\/10.1074\/jbc.M607954200 (2007).","journal-title":"J. Biol. Chem."},{"key":"12645_CR55","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.yexmp.2012.05.001","volume":"93","author":"NA Gandini","year":"2012","unstructured":"Gandini, N. A. et al. Nuclear localization of Heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas. Exp. Mol. Pathol. 93, 237\u2013245. https:\/\/doi.org\/10.1016\/j.yexmp.2012.05.001 (2012).","journal-title":"Exp. Mol. Pathol."},{"key":"12645_CR56","doi-asserted-by":"publisher","first-page":"394632023121934","DOI":"10.1177\/03946320231219348","volume":"37","author":"X Wei","year":"2023","unstructured":"Wei, X., Huang, Q., Huang, J., Yu, L. & Chen, J. Erastin induces ferroptosis in cervical cancer cells via Nrf2\/HO-1 signaling pathway. Int. J. Immunopathol. Pharmacol. 37, 3946320231219348. https:\/\/doi.org\/10.1177\/03946320231219348 (2023).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"12645_CR57","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/cbdd.12015","volume":"80","author":"V Sorrenti","year":"2012","unstructured":"Sorrenti, V. et al. Evaluation of imidazole-based compounds as Heme oxygenase-1 inhibitors. Chem. Biol. Drug Des. 80, 876\u2013886. https:\/\/doi.org\/10.1111\/cbdd.12015 (2012).","journal-title":"Chem. Biol. Drug Des."},{"key":"12645_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ejmech.2018.02.007","volume":"148","author":"L Salerno","year":"2018","unstructured":"Salerno, L. et al. Potholing of the hydrophobic Heme oxygenase-1 Western region for the search of potent and selective imidazole-based inhibitors. Eur. J. Med. Chem. 148, 54\u201362. https:\/\/doi.org\/10.1016\/j.ejmech.2018.02.007 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"12645_CR59","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/cmdc.201700321","volume":"12","author":"E Amata","year":"2017","unstructured":"Amata, E. et al. Heme Oxygenase database (HemeOxDB) and QSAR analysis of isoform 1 inhibitors. ChemMedChem 12, 1873\u20131881. https:\/\/doi.org\/10.1002\/cmdc.201700321 (2017).","journal-title":"ChemMedChem"},{"key":"12645_CR60","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-030-26780-3_6","volume-title":"Ferroptosis in Health and Disease","author":"Q Ran","year":"2019","unstructured":"Ran, Q. & Mozolewska, P. Gpx4 and ferroptosis. In: (ed Tang, D.) Ferroptosis in Health and Disease, (Springer International Publishing, 2019)."},{"key":"12645_CR61","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.freeradbiomed.2018.09.014","volume":"133","author":"TM Seibt","year":"2019","unstructured":"Seibt, T. M., Proneth, B. & Conrad, M. Role of GPX4 in ferroptosis and its pharmacological implication. Free Radic Biol. Med. 133, 144\u2013152. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.09.014 (2019).","journal-title":"Free Radic Biol. Med."},{"key":"12645_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","volume":"156","author":"WS Yang","year":"2014","unstructured":"Yang, W. S. et al. Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317\u2013331. https:\/\/doi.org\/10.1016\/j.cell.2013.12.010 (2014).","journal-title":"Cell"},{"key":"12645_CR63","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang, D., Chen, X., Kang, R. & Kroemer, G. Ferroptosis: molecular mechanisms and health implications. Cell. Res. 31, 107\u2013125. https:\/\/doi.org\/10.1038\/s41422-020-00441-1 (2021).","journal-title":"Cell. Res."},{"key":"12645_CR64","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10565-025-10010-0","volume":"41","author":"SY Xu","year":"2025","unstructured":"Xu, S. Y. et al. Insights into emerging mechanisms of ferroptosis: new regulators for cancer therapeutics. Cell. Biol. Toxicol. 41, 63. https:\/\/doi.org\/10.1007\/s10565-025-10010-0 (2025).","journal-title":"Cell. Biol. Toxicol."},{"key":"12645_CR65","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s40139-017-0139-5","volume":"5","author":"R Kang","year":"2017","unstructured":"Kang, R. & Tang, D. Autophagy and Ferroptosis - What\u2019s the connection?? Curr. Pathobiol Rep. 5, 153\u2013159. https:\/\/doi.org\/10.1007\/s40139-017-0139-5 (2017).","journal-title":"Curr. Pathobiol Rep."},{"key":"12645_CR66","doi-asserted-by":"publisher","first-page":"1043344","DOI":"10.3389\/fphar.2022.1043344","volume":"13","author":"K Sun","year":"2022","unstructured":"Sun, K. et al. Ferritinophagy, a form of autophagic ferroptosis: new insights into cancer treatment. Front. Pharmacol. 13, 1043344. https:\/\/doi.org\/10.3389\/fphar.2022.1043344 (2022).","journal-title":"Front. Pharmacol."},{"key":"12645_CR67","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41420-023-01753-y","volume":"9","author":"J Wang","year":"2023","unstructured":"Wang, J. et al. Ferritinophagy: research advance and clinical significance in cancers. Cell. Death Discov. 9, 463. https:\/\/doi.org\/10.1038\/s41420-023-01753-y (2023).","journal-title":"Cell. Death Discov"},{"key":"12645_CR68","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-3-030-62026-4_4","volume":"1301","author":"N Santana-Codina","year":"2021","unstructured":"Santana-Codina, N., Gikandi, A. & Mancias, J. D. The role of NCOA4-Mediated ferritinophagy in ferroptosis. Adv. Exp. Med. Biol. 1301, 41\u201357. https:\/\/doi.org\/10.1007\/978-3-030-62026-4_4 (2021).","journal-title":"Adv. Exp. Med. Biol."},{"key":"12645_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-025-00843-2","author":"E Mishima","year":"2025","unstructured":"Mishima, E. et al. Recommendations for robust and reproducible research on ferroptosis. Nat. Rev. Mol. Cell. Biol. Doi. https:\/\/doi.org\/10.1038\/s41580-025-00843-2 (2025).","journal-title":"Nat. Rev. Mol. Cell. Biol. Doi"},{"key":"12645_CR70","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41420-023-01773-8","volume":"10","author":"V Tonelotto","year":"2024","unstructured":"Tonelotto, V. et al. 1,4-dihydroxy Quininib activates ferroptosis pathways in metastatic uveal melanoma and reveals a novel prognostic biomarker signature. Cell. Death Discov. 10, 70. https:\/\/doi.org\/10.1038\/s41420-023-01773-8 (2024).","journal-title":"Cell. Death Discov"},{"key":"12645_CR71","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1111\/jcmm.14594","volume":"23","author":"T Bai","year":"2019","unstructured":"Bai, T. et al. Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells. J. Cell. Mol. Med. 23, 7349\u20137359. https:\/\/doi.org\/10.1111\/jcmm.14594 (2019).","journal-title":"J. Cell. Mol. Med."},{"key":"12645_CR72","doi-asserted-by":"publisher","unstructured":"Nguyen, N. T. et al. Sigma receptors: novel regulators of iron\/heme homeostasis and ferroptosis. Int. J. Mol. Sci. 24 https:\/\/doi.org\/10.3390\/ijms241914672 (2023).","DOI":"10.3390\/ijms241914672"},{"key":"12645_CR73","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s0031-6865(99)00034-5","volume":"74","author":"WD Bowen","year":"2000","unstructured":"Bowen, W. D. Sigma receptors: recent advances and new clinical potentials. Pharm. Acta Helv. 74, 211\u2013218. https:\/\/doi.org\/10.1016\/s0031-6865(99)00034-5 (2000).","journal-title":"Pharm. Acta Helv."},{"key":"12645_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-50174-1_1","volume":"964","author":"SB Smith","year":"2017","unstructured":"Smith, S. B. Introduction to Sigma receptors: their role in disease and as therapeutic targets. Adv. Exp. Med. Biol. 964, 1\u20134. https:\/\/doi.org\/10.1007\/978-3-319-50174-1_1 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"12645_CR75","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1158\/0008-5472.CAN-15-1465","volume":"76","author":"D Crott\u00e8s","year":"2016","unstructured":"Crott\u00e8s, D. et al. SIGMAR1 regulates membrane electrical activity in response to extracellular matrix stimulation to drive Cancer cell invasiveness. Cancer Res. 76, 607\u2013618. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-1465 (2016).","journal-title":"Cancer Res."},{"key":"12645_CR76","doi-asserted-by":"publisher","first-page":"13622","DOI":"10.1021\/acs.jmedchem.1c00995","volume":"64","author":"C Barbaraci","year":"2021","unstructured":"Barbaraci, C. et al. Haloperidol metabolite II valproate ester. (J Med. Chem. 64, 13622\u201313632. https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00995 (2021).","journal-title":"(J Med. Chem."},{"key":"12645_CR77","doi-asserted-by":"publisher","first-page":"91099","DOI":"10.18632\/oncotarget.19556","volume":"8","author":"L Longhitano","year":"2017","unstructured":"Longhitano, L. et al. Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma. Oncotarget 8, 91099\u201391111. https:\/\/doi.org\/10.18632\/oncotarget.19556 (2017).","journal-title":"Oncotarget"},{"key":"12645_CR78","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/BF02244985","volume":"114","author":"B Cusack","year":"1994","unstructured":"Cusack, B., Nelson, A. & Richelson, E. Binding of antidepressants to human brain receptors: focus on newer generation compounds. Psychopharmacol. (Berl). 114, 559\u2013565. https:\/\/doi.org\/10.1007\/BF02244985 (1994).","journal-title":"Psychopharmacol. (Berl)"},{"key":"12645_CR79","doi-asserted-by":"publisher","unstructured":"Abatematteo, F. S., Niso, M., Lacivita, E. & Abate, C. \u03c32 receptor and its role in Cancer with focus on a multitarget directed ligand (MTDL) approach. Molecules 26 https:\/\/doi.org\/10.3390\/molecules26123743 (2021).","DOI":"10.3390\/molecules26123743"},{"key":"12645_CR80","doi-asserted-by":"publisher","first-page":"2026","DOI":"10.1002\/cmdc.201300291","volume":"8","author":"M Niso","year":"2013","unstructured":"Niso, M. et al. Sigma-2 receptor agonists as possible antitumor agents in resistant tumors: hints for collateral sensitivity. ChemMedChem 8, 2026\u20132035. https:\/\/doi.org\/10.1002\/cmdc.201300291 (2013).","journal-title":"ChemMedChem"},{"key":"12645_CR81","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.canlet.2005.11.011","volume":"242","author":"E Aydar","year":"2006","unstructured":"Aydar, E., Onganer, P., Perrett, R., Djamgoz, M. B. & Palmer, C. P. The expression and functional characterization of Sigma (sigma) 1 receptors in breast cancer cell lines. Cancer Lett. 242, 245\u2013257. https:\/\/doi.org\/10.1016\/j.canlet.2005.11.011 (2006).","journal-title":"Cancer Lett."},{"key":"12645_CR82","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00213-005-0127-z","volume":"182","author":"CM Cend\u00e1n","year":"2005","unstructured":"Cend\u00e1n, C. M., Pujalte, J. M., Portillo-Salido, E. & Baeyens, J. M. Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice. Psychopharmacol. (Berl). 182, 485\u2013493. https:\/\/doi.org\/10.1007\/s00213-005-0127-z (2005).","journal-title":"Psychopharmacol. (Berl)"},{"key":"12645_CR83","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1158\/1078-0432.CCR-22-3971","volume":"29","author":"L Shi","year":"2023","unstructured":"Shi, L. et al. The DRD2 antagonist haloperidol mediates Autophagy-Induced ferroptosis to increase Temozolomide sensitivity by promoting Endoplasmic reticulum stress in glioblastoma. Clin. Cancer Res. 29, 3172\u20133188. https:\/\/doi.org\/10.1158\/1078-0432.CCR-22-3971 (2023).","journal-title":"Clin. Cancer Res."},{"key":"12645_CR84","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1053\/j.gastro.2016.08.040","volume":"151","author":"P Jandaghi","year":"2016","unstructured":"Jandaghi, P. et al. Expression of DRD2 is increased in human pancreatic ductal adenocarcinoma and inhibitors slow tumor growth in mice. Gastroenterology 151, 1218\u20131231. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.040 (2016).","journal-title":"Gastroenterology"},{"key":"12645_CR85","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/neuonc\/noz030","volume":"21","author":"AL Marisetty","year":"2019","unstructured":"Marisetty, A. L. et al. REST-DRD2 mechanism impacts glioblastoma stem cell-mediated tumorigenesis. Neuro Oncol. 21, 775\u2013785. https:\/\/doi.org\/10.1093\/neuonc\/noz030 (2019).","journal-title":"Neuro Oncol."},{"key":"12645_CR86","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.21037\/tcr-22-783","volume":"11","author":"A Rosas-Cruz","year":"2022","unstructured":"Rosas-Cruz, A., Salinas-Jazm\u00edn, N., Vald\u00e9s-Rives, A. & Velasco-Vel\u00e1zquez, M. A. DRD1 and DRD4 are differentially expressed in breast tumors and breast cancer stem cells: Pharmacological implications. Transl Cancer Res. 11, 3941\u20133950. https:\/\/doi.org\/10.21037\/tcr-22-783 (2022).","journal-title":"Transl Cancer Res."},{"key":"12645_CR87","doi-asserted-by":"publisher","first-page":"19103","DOI":"10.1038\/srep19103","volume":"6","author":"M Zanoni","year":"2016","unstructured":"Zanoni, M. et al. 3D tumor spheroid models for in vitro therapeutic screening: a systematic approach to enhance the biological relevance of data obtained. Sci. Rep. 6, 19103. https:\/\/doi.org\/10.1038\/srep19103 (2016).","journal-title":"Sci. Rep."},{"key":"12645_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03230-x","author":"E Rodrigues Sousa","year":"2024","unstructured":"Rodrigues Sousa, E. et al. CRIPTO\u2019s multifaceted role in driving aggressive prostate cancer unveiled by in vivo, organoid, and patient data. Oncogene https:\/\/doi.org\/10.1038\/s41388-024-03230-x (2024).","journal-title":"Oncogene"},{"key":"12645_CR89","doi-asserted-by":"publisher","unstructured":"Paris, F. et al. Characterization of perinatal stem cell spheroids for the development of cell therapy strategy. Bioeng. (Basel). 10. https:\/\/doi.org\/10.3390\/bioengineering10020189 (2023).","DOI":"10.3390\/bioengineering10020189"},{"key":"12645_CR90","doi-asserted-by":"publisher","first-page":"e0252907","DOI":"10.1371\/journal.pone.0252907","volume":"16","author":"A Sargenti","year":"2021","unstructured":"Sargenti, A. et al. A new method for the study of biophysical and morphological parameters in 3D cell cultures: evaluation in LoVo spheroids treated with Crizotinib. PLoS One. 16, e0252907. https:\/\/doi.org\/10.1371\/journal.pone.0252907 (2021).","journal-title":"PLoS One"},{"key":"12645_CR91","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/j.molcel.2020.11.022","volume":"80","author":"WL Wu","year":"2020","unstructured":"Wu, W. L. & Papagiannakopoulos, T. The center cannot hold: NRF2 battles ferroptosis in the 3rd dimension. Mol. Cell. 80, 760\u2013761. https:\/\/doi.org\/10.1016\/j.molcel.2020.11.022 (2020).","journal-title":"Mol. Cell."},{"key":"12645_CR92","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.molcel.2020.10.010","volume":"80","author":"N Takahashi","year":"2020","unstructured":"Takahashi, N. et al. 3D culture models with CRISPR screens reveal hyperactive NRF2 as a prerequisite for spheroid formation via regulation of proliferation and ferroptosis. Mol. Cell. 80, 828\u2013844e6. https:\/\/doi.org\/10.1016\/j.molcel.2020.10.010 (2020).","journal-title":"Mol. Cell."},{"key":"12645_CR93","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.ajpath.2013.08.002","volume":"183","author":"AG Rivenbark","year":"2013","unstructured":"Rivenbark, A. G., O\u2019Connor, S. M. & Coleman, W. B. Molecular and cellular heterogeneity in breast cancer: challenges for personalized medicine. Am. J. Pathol. 183, 1113\u20131124. https:\/\/doi.org\/10.1016\/j.ajpath.2013.08.002 (2013).","journal-title":"Am. J. Pathol."},{"key":"12645_CR94","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.mce.2015.09.035","volume":"3","author":"R Clarke","year":"2015","unstructured":"Clarke, R., Tyson, J. J. & Dixon, J. M. Endocrine resistance in breast cancer\u2013An overview and update. Mol. Cell. Endocrinol. 418 Pt. 3, 220\u2013234. https:\/\/doi.org\/10.1016\/j.mce.2015.09.035 (2015).","journal-title":"Mol. Cell. Endocrinol. 418 Pt"},{"key":"12645_CR95","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41419-025-07354-0","volume":"16","author":"J Cao","year":"2025","unstructured":"Cao, J. et al. Targeting estrogen-regulated system x. Cell. Death Dis. 16, 30. https:\/\/doi.org\/10.1038\/s41419-025-07354-0 (2025).","journal-title":"Cell. Death Dis."},{"key":"12645_CR96","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41523-024-00685-9","volume":"10","author":"K Hu","year":"2024","unstructured":"Hu, K. et al. Efficacy of ferscore in predicting sensitivity to ferroptosis inducers in breast cancer. NPJ Breast Cancer. 10, 74. https:\/\/doi.org\/10.1038\/s41523-024-00685-9 (2024).","journal-title":"NPJ Breast Cancer"},{"key":"12645_CR97","doi-asserted-by":"publisher","first-page":"111869","DOI":"10.1016\/j.cellsig.2025.111869","volume":"134","author":"B Wang","year":"2025","unstructured":"Wang, B. et al. Role of ferroptosis in breast cancer: molecular mechanisms and therapeutic interventions. Cell. Signal. 134, 111869. https:\/\/doi.org\/10.1016\/j.cellsig.2025.111869 (2025).","journal-title":"Cell. Signal."},{"key":"12645_CR98","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/s44321-024-00090-6","volume":"16","author":"N Lorito","year":"2024","unstructured":"Lorito, N. et al. FADS1\/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer. EMBO Mol. Med. 16, 1533\u20131559. https:\/\/doi.org\/10.1038\/s44321-024-00090-6 (2024).","journal-title":"EMBO Mol. Med."},{"key":"12645_CR99","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1176\/ajp.149.4.500","volume":"149","author":"T Van Putten","year":"1992","unstructured":"Van Putten, T., Marder, S. R., Mintz, J. & Poland, R. E. Haloperidol plasma levels and clinical response: a therapeutic window relationship. Am. J. Psychiatry. 149, 500\u2013505. https:\/\/doi.org\/10.1176\/ajp.149.4.500 (1992).","journal-title":"Am. J. Psychiatry"},{"key":"12645_CR100","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1055\/s-2007-979322","volume":"31","author":"S Ulrich","year":"1998","unstructured":"Ulrich, S., Neuhof, S., Braun, V. & Meyer, F. P. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder. Pharmacopsychiatry 31, 163\u2013169. https:\/\/doi.org\/10.1055\/s-2007-979322 (1998).","journal-title":"Pharmacopsychiatry"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12645-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12645-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12645-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T21:57:38Z","timestamp":1757282258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12645-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12645"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12645-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"13 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Domenico Andrea Cristaldi is one of the inventors of Patent No. 102020000006031. Other Authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26948"}}